Patient preferences for clinical attributes of metastatic melanoma treatment with targeted therapy and immunotherapy

被引：1
|
作者：
Mansfield, Carol
Ndife, Briana
Chen, Joyce S.
Gallaher, Kathleen
Ghate, Sameer R.
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21511
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Patient preferences for treatment of metastatic melanoma
    Mansfield, Carol
    Ndife, Briana
    Chen, Joyce
    Gallaher, Kathleen
    Ghate, Sameer
    FUTURE ONCOLOGY, 2019, 15 (11) : 1255 - 1268
  • [2] Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma
    Sobrevilla-Moreno, Nora
    Rivera-Sanchez, Daniel
    Garcia-Ortega, Dorian Y.
    Lopez-Macias, Diego
    Garcilazo-Reyes, Alexandra
    Alvarez-Avitia, Miguel A.
    ONCOLOGY-NEW YORK, 2021, 35 (09): : 562 - 566
  • [3] Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma
    LoRusso, Patricia M.
    Schalper, Kurt
    Sosman, Jeffrey
    PIGMENT CELL & MELANOMA RESEARCH, 2020, 33 (03) : 390 - 402
  • [4] Targeted α-therapy for treatment of metastatic melanoma
    Nedrow, Jessie
    McCarty, Greg
    Cortez, Angel
    Roy, Sanchita
    Sgouros, George
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma
    Keller, Hilary R.
    Zhang, Xin
    Li, Li
    Schaider, Helmut
    Wells, James W.
    ONCOTARGET, 2017, 8 (43) : 75675 - 75686
  • [6] Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
    Yu, Chune
    Liu, Xiaowei
    Yang, Jiqiao
    Zhang, Min
    Jin, Hongyu
    Ma, Xuelei
    Shi, Hubing
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [7] QUANTIFYING PATIENT PREFERENCES FOR TARGETED THERAPIES IN METASTATIC MELANOMA: A DISCRETECHOICE EXPERIMENT
    Mason, B.
    Mesana, L.
    Hallworth, P.
    Randhawa, S.
    Rezai, N.
    Hughes, O.
    Guenzel, C.
    Gater, A.
    Chen, K.
    Clifford, M.
    Hauber, B.
    Marin, L.
    Cappelleri, J.
    VALUE IN HEALTH, 2023, 26 (06) : S333 - S333
  • [8] Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    Hersey, Peter
    ONCOIMMUNOLOGY, 2012, 1 (06) : 997 - 999
  • [9] PET-guided Switch from Immunotherapy to Targeted Therapy in a Metastatic Melanoma Patient: a personalized approach
    Proieti, I
    Filippi, L.
    Michclini, S.
    Porta, N.
    Bernardini, N.
    Mambrin, A.
    Tolino, E.
    Pacini, L.
    Rosa, P.
    Calogero, A.
    Romeo, A.
    Di Cristofano, C.
    Petrozza, V
    Bagni, O.
    Skroza, N.
    Potenza, C.
    CLINICA TERAPEUTICA, 2020, 171 (04): : E283 - E287
  • [10] Targeted therapy followed by immunotherapy in a patient with advanced malignant melanoma
    Markiewicz-Bialek, Beata
    Bialek, Piotr
    Blasinska-Morawiec, Maria
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 : A26 - A27
12345